Sunday, 10 April 2005 - 8:40 AM

General Session: Pharmaceutical Agents in the Treatment of Osteoporosis

Novel Targets for Antiresorptive Agents

Roland Baron, DDS, PhD, Yale University School of Medicine, 333 Cedar Street, SHM IE 55, P.O. Box 208044, Dep't. of Orthopaedics, New Haven, CT 06510

Roland Baron, DDS, PhD is a tenured professor in Cell Biology and in Orthopedics and Director of Biological Research in the Department of Orthopedics, Yale University School of Medicine. He also is the President, Founder and Chief Scientific Officer of ProSkelia Pharmaceuticals.

Disclosure Information:

Faculty Member's Name: Roland Baron, DDS, PhD
I have no relationships to disclose.


[ Recorded presentation ]   Recorded presentation

See more of General Session: Pharmaceutical Agents in the Treatment of Osteoporosis
See more of The Sixth International Symposium on Osteoporosis: Current Status and Future Directions